article thumbnail

: Curaleaf wins renewal for NJ licenses after emergency meeting of state’s cannabis regulatory commission

MarketWatch

after New Jersey Cannabis Regulatory Commission on Monday approved a renewal of the Massachusetts-based company’s cultivation and retail licenses for adult-use in the Garden State, in a reversal of a decision last week, according to spokespeople for the commission and Curaleaf. Visit MarketWatch.com for more information on this news.

License 75
article thumbnail

: New York increases the number of conditional adult-use retail dispensary licenses to 300 from 150

MarketWatch

The New York State Office of Cannabis Management on Thursday said it’s increasing the number of conditional adult-use retail dispensary licenses to 300 from 150. At last check, the state has issued 66 provisional conditional adult-use retail dispensary (CAURD) licenses and four dispensaries have opened.

License 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

: Group of licensed medical cannabis operators file suit against New York regulator for failing to open licensing to all applicants at the same time

MarketWatch

A coalition of licensed medical cannabis operators has filed a lawsuit against the New York cannabis regulator, alleging it overstepped its authority and subverted the intent of the state legislature by failing to comply with provisions of the 2021 Marihuana Regulation and Taxation Act, or MRTA.

License 40
article thumbnail

: N.Y. clears legal hurdle to issue cannabis licenses in the Finger Lakes region, as pot stocks rise

MarketWatch

The New York State Cannabis Control Board on Tuesday approved a settlement to a lawsuit that prevented it from issuing licenses in the Finger Lakes region. Visit MarketWatch.com for more information on this news. The state approved the settlement with Variscite NY One Inc., The AdvisorShares Pure U.S. Cannabis ETF MSOS is up by 5.7%.

License 40
article thumbnail

: Iovance Biotherapeutics completes license application submission for advanced melanoma therapy; shares rally

MarketWatch

IOVA on Friday said it had completed its rolling biologics license application submission to the U.S. Visit MarketWatch.com for more information on this news. Biotech cancer-treatment developer Iovance Biotherapeutics Inc. Food and Drug Administration for lifileucel — a therapy intended to combat advanced melanoma in some cases.

License 40
article thumbnail

: Curaleaf stock tumbles toward record low after NJ denies license renewal, but analyst sees case for company to appeal and sue

MarketWatch

toward a record low in morning trading Friday, in the wake of the decision by the New Jersey Cannabis Regulatory Commission (CRC Board) to deny the renewal of the Massachusetts-based company’s cultivation and retail licenses for adult use. “We Visit MarketWatch.com for more information on this news. CURLFCA:CURA tumbled 10.2%

License 40
article thumbnail

Do What You Say You Will and Be Who You Say You Are

NAIFA Advisor Today

Glenn Crawford is a Certified Divorce Financial Analyst (CDFA®) and a licensed insurance agent holding a Series 65 Investment Advisor Representative distinction. Before entering the wealth management industry, he enjoyed a career in information technology and was a partner in a $65 million consultancy firm.

License 105